Creatine Monohydrate
Clinical DoseFuels ATP resynthesis and is studied for working memory support under conditions of sustained cognitive load.
Focus. Clarity. The Competitive Edge.
Traditional energy drink combined with clinical nootropics.
Early access. Exclusive launch pricing.
Limited early access. Secure your spot.
Eight compounds. Each with a defined mechanistic role supported by published clinical research.
Fuels ATP resynthesis and is studied for working memory support under conditions of sustained cognitive load.
Precursor to dopamine and norepinephrine, studied for executive function support during mental stress and sleep restriction.
Elevates acetylcholine synthesis, studied for its role in attention, memory consolidation, and neural efficiency.
Promotes nerve growth factor expression, studied for associations with neuroplasticity and cognitive resilience.
Modulates alpha-wave activity, associated in research with calm alertness without sedation or rebound anxiety.
Adenosine receptor antagonist delivering sustained stimulation with the crash profile blunted by co-administration of theanine.
Essential cofactor in the biosynthesis of serotonin, dopamine, and GABA, the neurotransmitters central to mood regulation, cognitive function, and mental energy.
Supports myelin sheath integrity and neurological function, with deficiency linked to cognitive impairment; essential for cellular energy production and mental clarity.
Every ingredient is dosed at the level shown to produce measurable cognitive effects in peer-reviewed research. Not the minimum to justify inclusion. The amount that actually works.
Phalanx is formulated and manufactured to the highest regulatory standards. Every compound is legal, documented, and present at its declared amount. No grey-area substances. No hidden blends.
Every batch is third-party tested for purity, potency, and label accuracy. What is declared on the label is what is in the can. No exceptions.
Several ingredients in this formula, including Lion's Mane, Citicoline, and Creatine, have peer-reviewed evidence linking regular use to reduced risk of neurodegenerative disease, including Alzheimer's and stroke. Performance today. Protection long term.
Most energy drinks produce stimulation through caffeine and sugar, which generates a brief spike followed by a predictable crash. Phalanx pairs caffeine with L-theanine at a clinically studied ratio. L-theanine attenuates the stimulant response, producing more sustained alertness. The result is steady energy without the crash: alertness that holds across a full work session, not just the first hour.
Every ingredient in the Phalanx formula is selected on the basis of human clinical research. Citicoline, L-tyrosine, creatine, and Lion's Mane are included because published studies at the relevant doses demonstrate measurable cognitive effects. Dosing follows the quantities used in those studies, not the minimum required to justify inclusion on the label.
Phalanx is a nootropic energy drink developed for the Swedish market, incorporating a full nootropic ingredient stack. The formula is manufactured to regulatory standards applicable in Sweden and the EU, with independent batch testing confirming that each ingredient is present at its declared amount.
Phalanx is formulated for contexts that require sustained cognitive output: examinations, extended professional work sessions, or any situation where attention and working memory need to hold over several hours. The formula is designed to support cognitive performance without introducing the stimulant crash that limits the utility of most energy drinks.
Production is underway. The first release is limited. Register for early access and pre-launch notification.
By registering you agree to receive pre-launch updates. Unsubscribe at any time.
Phalanx is a nootropic energy drink formulated to support sustained cognitive performance. It combines caffeine with L-theanine, citicoline, Lion's Mane, L-tyrosine, creatine, and B vitamins in a formula designed to support focus and mental output without the energy crash typical of drinks high in sugar and caffeine.
Phalanx is scheduled to launch in September 2026. The first production run is limited to 500 units. Waitlist members receive early notification and have priority access to the initial batch. Registering on the waitlist does not constitute a purchase commitment.
Phalanx was created to address a gap between two existing categories: conventional energy drinks formulated around caffeine and sugar, and nootropic supplement stacks requiring multiple capsules taken at separate times. The goal was to consolidate a complete, clinically referenced nootropic formula into a single drink. Every compound is present at the dose used in the published clinical studies that informed its inclusion, not the minimum required to justify placement on the label.
The primary difference is in the selection criteria applied during formulation. Most energy drinks are built around palatability and stimulant intensity, with ingredients chosen to produce a noticeable immediate effect. Phalanx is built around a different criterion: the published clinical research on cognitive function. Every compound in the formula appears in human clinical trials at the dose used. The formula contains no sugar because sugar contributes no cognitive benefit and introduces the crash mechanism that most energy drinks produce. Phalanx represents a specific formulation standard, not a variation on the conventional energy drink format.
No. The crash associated with conventional energy drinks is primarily caused by high sugar content and unmodified caffeine spikes. Phalanx uses L-theanine to moderate the caffeine response, producing a steadier energy curve. The absence of added sugar eliminates the glucose crash entirely.
Yes. Every production batch of Phalanx is tested by an independent external laboratory to verify that each ingredient is present at its declared amount, that no undeclared substances are present, and that the product meets applicable purity standards. Test results are retained and available to confirm label accuracy. This verification process applies to every production run without exception.